眼科药物输送系统市场：按技术、生产技术、材料、输送途径分类 - 全球预测 2025-2030

2023年眼科给药系统市值为163.5亿美元，预计2024年将达到178.5亿美元，复合年增长率为9.59%，到2030年将达到310.4亿美元。

眼科药物传输系统包括多种旨在将药物输送到眼睛以治疗眼科疾病和疾病的技术和方法。由于眼睛独特的解剖结构以及在目标区域实现有效药物浓度的挑战，该领域在製药和医疗保健行业中至关重要。对此类系统的需求源于传统全身给药方法不足以有效的疾病，例如青光眼、黄斑部病变、干眼症和术后护理。各种给药系统，如眼药水、软膏、注射和植入，经过客製化以提高生物利用度和患者依从性。典型的最终用户包括医院、眼科诊所和居家医疗机构。

这个市场主要是由眼科疾病率上升、人口老化以及药物配方和输送技术的进步所推动的。奈米技术和生物分解性的药物释放型植入等发展改善了治疗结果和患者依从性，并为创新提供了有利的机会。然而，成长受到高研发成本、严格的监管要求以及限制药物渗透的眼生物学复杂性等因素的限制。此外，患者的依从性仍然是一个挑战，特别是需要长期给药时。

为了利用新的商机，公司应专注于研究并投资新配方，以开发非侵入性且对患者友善的药物输送系统。与学术机构和生物技术公司的合作可以刺激输送机制和材料的创新，扩大治疗的可能性。儘管存在挑战，个人化医疗和数位健康技术整合的进步可以将眼科药物传输系统定位为未来眼科治疗的基石。为了在这个快速发展的市场中保持竞争力，适应监管环境和优化成本结构至关重要，因为您需要根据技术进步和患者需求不断发展您的策略。

市场动态：快速发展的眼科给药系统市场的关键市场洞察

供给与需求的动态交互作用正在改变眼科给药系统市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

• 市场驱动因素
  • 人口老化导致眼科疾病增加
  • 人们越来越偏好早期诊断和预防
  • 加大政府在眼部保健方面的力度
• 市场限制因素
  • 眼科给药系统併发症的发生
• 市场机会
  • 眼科药物输送系统的不断进步
  • 优惠报销政策
• 市场挑战
  • 对溶解药物的低生物利用度和不稳定的担忧

波特五力：驾驭眼科给药系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解对眼科给药系统市场的外部影响

外部宏观环境因素在塑造眼科给药系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解眼科给药系统市场的竞争状况

对眼科药物输送系统市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵眼科给药系统市场供应商绩效评估

FPNV 定位矩阵是评估眼科给药系统市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定眼科给药系统市场成功之路的策略分析与建议

对于旨在加强在全球市场的影响力的公司来说，对眼科药物输送系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 老年人口眼科疾病增加
    • 对早期诊断和预防的兴趣增加
    • 扩大政府在眼部保健上的努力
  • 抑制因素
    • 与眼科药物传输系统相关的併发症
  • 机会
    • 眼科药物输送系统的不断进步
    • 优惠退款政策
  • 任务
    • 对溶解药物的低生物有效性和不稳定的担忧
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章眼科给药系统市场：依技术分类

• 隐形眼镜
• 植入外层植入物
• 眼药水
• 水凝胶
• 可注射颗粒系统
• 玻璃体内植入
• 离子电渗
• 微机电
• 微型针
• 奈米载体
• 奈米粒子
• 泪点塞

第七章眼科给药系统市场生产技术

• 3D列印
• 压缩成型
• 静电纺丝
• 挤压
• 处方
• 微图形化

第八章眼科给药系统市场：依材料分类

• 胶原蛋白
• 脂肪酸
• 水凝胶
• 脂质体
• PDO/PVA
• PLA-PEG
• PLGA
• 聚己内酯
• 聚原酸酯
• TMC

第九章眼科药物传输系统市场（依输送途径）

• 在前房
• 眼
• 玻璃体内

第十章北美及南美眼科给药系统市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第十一章亚太眼科给药系统市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十二章欧洲、中东和非洲眼科给药系统市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十三章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• AptarGroup, Inc.
• Bausch Health Companies Inc.
• Biocorp
• Envisia Therapeutics
• EyePoint Pharmaceuticals, Inc.
• Gerresheimer AG
• Mati Therapeutics, Inc.
• Merck & Co.
• Novartis AG
• Ocular Therapeutix Inc.
• Oculis Pharma
• Owen Mumford
• Pfizer Inc.
• Terumo Corporation
• Teva Pharmaceuticals

The Ophthalmic Drug Delivery System Market was valued at USD 16.35 billion in 2023, expected to reach USD 17.85 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 31.04 billion by 2030.

The ophthalmic drug delivery system encompasses a range of technologies and methods designed to deliver drugs to the eye for treating ocular conditions and diseases. This segment is pivotal in the pharmaceutical and healthcare industry due to the eye's unique anatomy and the challenges in achieving effective drug concentration in targeted areas. The necessity for such systems arises from conditions like glaucoma, macular degeneration, dry eye syndrome, and post-surgical care, where conventional systemic drug delivery methods fall short in efficacy. Various delivery systems, such as eye drops, ointments, injections, and implants, are tailored to improve bioavailability and patient compliance. Key end-users include hospitals, ophthalmic clinics, and homecare settings.

The market is primarily driven by the rising prevalence of eye disorders, an aging population, and advancements in drug formulations and delivery technologies. Developments such as nanotechnology and biodegradable drug-eluting implants present lucrative opportunities for innovation, offering enhanced therapeutic outcomes and patient adherence. However, growth is tempered by factors like high R&D costs, stringent regulatory requirements, and the complex nature of ocular biology that limits drug penetration. Moreover, patient compliance remains a challenge, especially with chronic administration requirements.

To capitalize on emerging opportunities, companies should focus on research to develop non-invasive, patient-friendly delivery systems and invest in novel drug formulations. Collaboration with academic institutions and biotech firms can spur innovation in delivery mechanisms and materials, thus expanding therapeutic potential. Despite existing challenges, advancements in personalized medicine and the integration of digital health technologies could position ophthalmic drug delivery systems as a cornerstone of future ocular therapies. It's crucial for businesses to navigate regulatory landscapes and optimize cost structures to remain competitive in this rapidly evolving market, which requires continuous evolution of strategies aligned with technological progress and patient needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of eye disorders in geriatric population
  • Increasing preference for early diagnosis and prevention
  • Growing government initiatives for eye care
• Market Restraints
  • Associated complications of ophthalmic drug delivery systems
• Market Opportunities
  • Ongoing advancements in ophthalmic drug delivery system
  • Favorable reimbursement policies
• Market Challenges
  • Concern regarding poor bioavailability and instability for dissolved drugs

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Drug Delivery System Market

A detailed market share analysis in the Ophthalmic Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Drug Delivery System Market

A strategic analysis of the Ophthalmic Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include AptarGroup, Inc., Bausch Health Companies Inc., Biocorp, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc., Gerresheimer AG, Mati Therapeutics, Inc., Merck & Co., Novartis AG, Ocular Therapeutix Inc., Oculis Pharma, Owen Mumford, Pfizer Inc., Terumo Corporation, and Teva Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Contact Lenses, Episcleral Implants, Eye Drops, Hydrogels, Injectable Particulate Systems, Intravitreal Implants, Iontophoresis, Micro-Electromechanical, Microneedles, Nano Careers, Nano Microparticles, and Punctal Plugs.
• Based on Production Technology, market is studied across 3D Printing, Compression Molding, Electrospinning, Extrusion, Formulation, and Micro Patterning.
• Based on Material, market is studied across Collagen, Fatty acids, Hydrogels, Liposomes, PDO/PVA, PLA-PEG, PLGA, Polycaprolactone, Polyorthoesters, and TMC.
• Based on Delivery Route, market is studied across Intracameral, Intraocular, and Intravitreal.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of eye disorders in geriatric population
    • 5.1.1.2. Increasing preference for early diagnosis and prevention
    • 5.1.1.3. Growing government initiatives for eye care
  • 5.1.2. Restraints
    • 5.1.2.1. Associated complications of ophthalmic drug delivery systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in ophthalmic drug delivery system
    • 5.1.3.2. Favorable reimbursement policies
  • 5.1.4. Challenges
    • 5.1.4.1. Concern regarding poor bioavailability and instability for dissolved drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Ophthalmic Drug Delivery System Market, by Technology

• 6.1. Introduction
• 6.2. Contact Lenses
• 6.3. Episcleral Implants
• 6.4. Eye Drops
• 6.5. Hydrogels
• 6.6. Injectable Particulate Systems
• 6.7. Intravitreal Implants
• 6.8. Iontophoresis
• 6.9. Micro-Electromechanical
• 6.10. Microneedles
• 6.11. Nano Careers
• 6.12. Nano Microparticles
• 6.13. Punctal Plugs

7. Ophthalmic Drug Delivery System Market, by Production Technology

• 7.1. Introduction
• 7.2. 3D Printing
• 7.3. Compression Molding
• 7.4. Electrospinning
• 7.5. Extrusion
• 7.6. Formulation
• 7.7. Micro Patterning

8. Ophthalmic Drug Delivery System Market, by Material

• 8.1. Introduction
• 8.2. Collagen
• 8.3. Fatty acids
• 8.4. Hydrogels
• 8.5. Liposomes
• 8.6. PDO/PVA
• 8.7. PLA-PEG
• 8.8. PLGA
• 8.9. Polycaprolactone
• 8.10. Polyorthoesters
• 8.11. TMC

9. Ophthalmic Drug Delivery System Market, by Delivery Route

• 9.1. Introduction
• 9.2. Intracameral
• 9.3. Intraocular
• 9.4. Intravitreal

10. Americas Ophthalmic Drug Delivery System Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Ophthalmic Drug Delivery System Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Ophthalmic Drug Delivery System Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AptarGroup, Inc.
• 2. Bausch Health Companies Inc.
• 3. Biocorp
• 4. Envisia Therapeutics
• 5. EyePoint Pharmaceuticals, Inc.
• 6. Gerresheimer AG
• 7. Mati Therapeutics, Inc.
• 8. Merck & Co.
• 9. Novartis AG
• 10. Ocular Therapeutix Inc.
• 11. Oculis Pharma
• 12. Owen Mumford
• 13. Pfizer Inc.
• 14. Terumo Corporation
• 15. Teva Pharmaceuticals

LIST OF FIGURES

• FIGURE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EPISCLERAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE PARTICULATE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO-ELECTROMECHANICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO CAREERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO MICROPARTICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PUNCTAL PLUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COMPRESSION MOLDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTROSPINNING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO PATTERNING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PDO/PVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLA-PEG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYORTHOESTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TMC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRACAMERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 58. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 80. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 81. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 84. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 126. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 130. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 134. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 137. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 138. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 141. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 142. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 145. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 146. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 149. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 150. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 153. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 154. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 157. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 158. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 161. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 162. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 165. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 166. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 169. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 170. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 173. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 174. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 177. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 178. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 181. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 186. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 189. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 190. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 193. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 194. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 197. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 198. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 201. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 202. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 205. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 206. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 209. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 210. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 211. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023